Content about Serono

January 4, 2013
FDA approves new delivery method for MS drug

The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.

October 11, 2012
Merck KGaA to donate $1.3 million per year to academic MS research

A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.

June 6, 2012
Dr. Reddy's, Merck KGaA partner on biosimilars

A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.

May 16, 2012
Amneal adds blackberry flavoring to generic diabetes drug

Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.

March 8, 2012
Prime Therapeutics, Merck KGaA subsidiary enter contractual agreement over MS drug

A pharmacy benefit manager and the U.S. subsidiary of a German drug maker have made a deal concerning a drug for multiple sclerosis.

December 21, 2011
Genzyme reports lackluster results in MS drug trial

An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.

October 6, 2011
Merck KGaA, Ono sign agreement for oral MS, cancer drugs

German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

July 7, 2011
Merck Serono names new COO

Merck KGaA division Merck Serono has appointed Belen Garijo as COO and Annalisa Jenkins as global head of drug development and medical, effective Sept. 5.

March 3, 2011
Merck receives CRL for MS treatment

The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.

November 29, 2010
FDA review of MS drug extended, EMD Serono says

The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.

June 16, 2010
Clinical trial for Merck KGaA's cancer vaccine continues

A division of German drug maker Merck KGaA has resumed its clinical trial of a...

© 2013 Drug Store News. All Rights Reserved.